8-K 1 a2156890z8-k.htm 8-K
QuickLinks -- Click here to rapidly navigate through this document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 28, 2005

NUTRACEUTICAL INTERNATIONAL CORPORATION
(Exact name of registrant as specified in its charter)

Delaware   000-23731   87-0515089
(State of
incorporation)		   (Commission
File Number)		   (IRS Employer
Identification No.)

 
 
 
 
 
1400 Kearns Boulevard, 2nd Floor
Park City, Utah		   84060
(Address of principal executive offices)   (Zip Code)

Registrant's telephone number, including area code: (435) 655-6106

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 2.02 Results of Operations and Financial Condition.

        On April 28, 2005, Nutraceutical International Corporation reported results for the fiscal 2005 second quarter and six months ended March 31, 2005 in a press release, a copy of which is attached to this Form 8-K as Exhibit 99.1.


Item 9.01 Financial Statements and Exhibits.

        Exhibits.

    99.1
    Press release issued by Nutraceutical dated April 28, 2005.

        This Form 8-K and the attached Exhibit are furnished to comply with Item 2.02 and Item 9.01 of Form 8-K. Neither this Form 8-K nor the attached Exhibit are to be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall this Form 8-K nor the attached Exhibit be deemed incorporated by reference in any filing under the Securities Act of 1933 (except as shall be expressly set forth by specific reference in such filing).


SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
 
NUTRACEUTICAL INTERNATIONAL CORPORATION
(Registrant)

Date: April 28, 2005
 
By:
 
/s/  LESLIE M. BROWN, JR.      
Leslie M. Brown, Jr.
Senior Vice President, Finance, Chief Financial Officer and Assistant Secretary
(Principal Financial and Accounting Officer)


EXHIBIT INDEX

Exhibit Number
   Description
99.1   Press release issued by Nutraceutical dated April 28, 2005.



QuickLinks

SIGNATURES
EXHIBIT INDEX